Member Exclusive

Gene-modified mesenchymal stem cells as a potential treatment for Huntington's disease: preparing for a planned Phase I clinical trial

Available to view on demand. The UC Davis research team present an update on preclinical development of the cell-gene therapy product and the planned Phase I trial.

Go to the profile of RegMedNet
Sep 24, 2015

Please sign in or register for FREE

No comments yet.